| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $26.5M | — | +29.3% |
| Cost of Revenue | $3.4M | — | +35.7% |
| Gross Profit | $23.1M | — | +28.4% |
| R&D Expense | $6.2M | — | +45.1% |
| SG&A Expense | $15.3M | — | +54.2% |
| Operating Income | -$20.7M | — | -46.0% |
| Pre-tax Income | -$19.7M | — | -54.5% |
| Net Income | -$19.7M | — | -54.5% |
| EPS (Basic) | -$0.52 | — | -44.4% |
| EPS (Diluted) | -$0.52 | — | -44.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $45.3M | +11.8% | -70.5% |
| Short-term Investments | $95.9M | -19.2% | +227.0% |
| Accounts Receivable | $15.7M | +4.4% | +39.1% |
| Inventory | $6.9M | -5.3% | +5.3% |
| Current Assets | $168.9M | -9.5% | -17.8% |
| Total Assets | $178.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.3M | — | -69.2% |
| Capital Expenditures | $125K | — | -15.5% |
| Investing Cash Flow | $22.4M | — | +175.8% |
| Financing Cash Flow | $1.6M | — | — |
| Free Cash Flow | -$19.4M | — | -68.1% |
| -16.6% |
| Current Liabilities | $16.2M | -15.7% | +36.8% |
| Total Liabilities | $37.3M | -7.9% | +14.3% |
| Stockholders' Equity | $140.8M | -9.3% | -22.2% |